Komori
GLOME Holdings (8938) · FactRestated

Payment of dividends on common shares

First written in FY2017-Q1. 21 of 33 entries say "Restated". Latest entry: FY2027-H1.

33entries
11years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q1 – FY2020-Q22016: 22017: 420172018: 420182019: 420192020: 120202021: 320212022: 320222023: 320232024: 320242025: 220252026: 42026
Same theme, other companies
Payment of dividends to shareholdersA theme 250 companies write about · 4 as a headwind · 335 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 144 companies compared. The sentences above are computed from all 144.Comparing 200 of the theme's 340 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1RestatedAnnual report

    「Interim consolidated accounting period (from 1 April 2026 to 30 September 2026): Dividends paid: Not applicable.」

    No dividends were paid during the interim consolidated accounting period, and the non-dividend-paying status indicated for FY2026 continues.
  2. 2026-08-14AdvancedResults

    「Fiscal year ending March 2027 (forecast) 0.00 — 3.00 3.00」

    FY2026の無配から、FY2027は期末配当3円、年間配当3円の予想が示された。
  3. FY2026SoftenedAnnual report

    「Based on this basic policy, no year-end dividend is being paid for the fiscal year ending March 2026.」

    The dividend changed from ¥2 per share in FY2025 to no dividend in FY2026.
  4. 2026-05-15SoftenedResults

    「Fiscal year ending March 2026 — 0.00 — 0.00 0.00 — — —」

    前期の1株当たり2円配当から、2026年3月期は無配となった。
  5. FY2026-H1AchievedAnnual report

    「26 June 2025 Annual General Meeting of Shareholders Common shares 18 2.00 31 March 2025 27 June 2025 Retained earnings」

    A FY2025 year-end dividend of ¥2 per common share, totaling ¥18 million, was paid.
  6. FY2025AdvancedAnnual report

    「Based on this basic policy, it was resolved at the 33rd Annual General Meeting of Shareholders held on 26 June 2025 that the year-end dividend for the fiscal year would be ¥2 per share, totaling ¥18 million.」

    The dividend changed from no dividend in FY2024 to a FY2025 year-end dividend of ¥2 per share, totaling ¥18 million.
  7. FY2025-H1RestatedAnnual report

    「Not applicable.」

    No dividends were paid during the interim consolidated accounting period, and the FY2024 no-dividend policy continued through the interim period.
  8. FY2024SoftenedAnnual report

    「Based on this basic policy, it was resolved at the 32nd Annual General Meeting of Shareholders held on 27 June 2024 that no year-end dividend would be paid for the fiscal year.」

    The dividend changed from ¥5 per share in the previous fiscal year to no dividend in FY2024.
  9. FY2024-Q3RestatedAnnual report

    「28 June 2023 Annual General Meeting of Shareholders Common stock 45 5.00 31 March 2023 29 June 2023 Retained earnings」

    It has been reconfirmed that ¥5 per common share, totaling ¥45 million, was paid as the FY2023 year-end dividend.
  10. FY2024-Q2RestatedAnnual report

    「28 June 2023 Annual General Meeting of Shareholders Common stock 45 5.00 31 March 2023 29 June 2023 Retained earnings」

    It has been reconfirmed that ¥5 per common share, totaling ¥45 million, was paid as the FY2023 year-end dividend.
  11. FY2024-Q1SoftenedAnnual report

    「28 June 2023 Annual General Meeting of Shareholders Common stock 45 5.00 31 March 2023 29 June 2023 Retained earnings」

    For the FY2023 year-end dividend, ¥5 per share was paid on common stock, for a total of ¥45 million. This was down from ¥6 per share in the previous fiscal year.
  12. FY2023-Q3RestatedAnnual report

    「27 June 2022 Annual General Meeting of Shareholders Common stock 54 6.00 31 March 2022 28 June 2022 Retained earnings」

    For the FY2022 year-end dividend, payment of ¥6 per share on common stock, for a total of ¥54 million, was also confirmed for the nine-month cumulative period.
  13. FY2023-Q2RestatedAnnual report

    「27 June 2022 Annual General Meeting of Shareholders Common stock 54 6.00 31 March 2022 28 June 2022 Retained earnings」

    For the FY2022 year-end dividend, payment of ¥6 per share on common stock, for a total of ¥54 million, was also confirmed for the six-month cumulative period.
  14. FY2023-Q1AdvancedAnnual report

    「27 June 2022 Annual General Meeting of Shareholders Common stock 54 6.00 31 March 2022 28 June 2022 Retained earnings」

    For the FY2022 year-end dividend, ¥6 per share was paid on common stock, for a total of ¥54 million. The payment of the dividend approved after no dividends in FY2020 and FY2021 has been confirmed.
  15. FY2022AdvancedAnnual report

    「Under this basic policy, the year-end dividend for the current fiscal year was resolved at ¥6 per share at the 30th Annual General Meeting of Shareholders held on 27 June 2022.」

    After no dividends in FY2020 and FY2021, a year-end dividend of ¥6 per share was approved and dividend payments resumed.
  16. FY2022-Q2RestatedAnnual report

    「Not applicable.」

    No dividends were paid during the six months, and the no-dividend status continued.
  17. FY2021RestatedAnnual report

    「In light of the performance of the previous and current fiscal years, the Company decided not to pay a dividend for the current fiscal year under a policy of strengthening the Group's financial position and securing funds available for investment so that it can provide stable financial support to medical institutions facing the COVID-19 pandemic.」

    No dividend was paid for the fiscal year, continuing the policy from the previous fiscal year.
  18. FY2021-Q3RestatedAnnual report

    「Not applicable.」

    No dividends were paid during the nine months, and the no-dividend status disclosed for the previous fiscal year continued.
  19. FY2020SoftenedAnnual report

    「After comprehensively considering the current year's performance, financial condition and efforts to reform the earnings structure going forward, the Company regrettably decided not to pay a dividend for the fiscal year.」

    Although a year-end dividend of ¥5 per share had been paid through the previous fiscal year, no dividend was paid for the current fiscal year.
  20. FY2020-Q2RestatedAnnual report

    「27 June 2019 Annual General Meeting of Shareholders Common stock 27 5.00」

    The repeat disclosure states that a ¥5 per-share dividend was paid on common stock for the fiscal year ended March 2019.
  21. FY2020-Q1RestatedAnnual report

    「27 June 2019 Annual General Meeting of Shareholders Common stock 27 5.00」

    The payment of a ¥5 per-share dividend on common stock for the fiscal year ended March 2019 is disclosed.
  22. FY2019RestatedAnnual report

    「The Company decided to pay a year-end dividend of ¥5 per share for the current fiscal year, funded from retained earnings.」

    The year-end dividend on common stock has remained at ¥5 per share.
  23. FY2019-Q3RestatedAnnual report

    「27 June 2018 Annual General Meeting of Shareholders Common stock 27,799 5.00」

    The repeat disclosure states that a ¥5 per-share dividend was paid on common stock for the fiscal year ended March 2018.
  24. FY2019-Q2RestatedAnnual report

    「27 June 2018 Annual General Meeting of Shareholders Common stock 27,799 5.00」

    The repeat disclosure states that a ¥5 per-share dividend was paid on common stock for the fiscal year ended March 2018.
  25. FY2019-Q1RestatedAnnual report

    「27 June 2018 Annual General Meeting of Shareholders Common stock 27,799 5.00」

    The payment of a ¥5 per-share dividend on common stock is disclosed.
  26. FY2018RestatedAnnual report

    「The Company decided to pay a year-end dividend of ¥5 per share for the current fiscal year, funded from retained earnings.」

    Under its policy of paying stable dividends in line with performance, the Company has continued to pay a year-end dividend of ¥5 per share.
  27. FY2018-Q3RestatedAnnual report

    「28 June 2017 Annual General Meeting of Shareholders Common stock 27,799 5.00」

    The payment of a ¥5 per-share dividend on common stock is disclosed again.
  28. FY2018-Q2RestatedAnnual report

    「28 June 2017 Annual General Meeting of Shareholders Common stock 27,799 5.00」

    The payment of a ¥5 per-share dividend on common stock is disclosed again.
  29. FY2018-Q1RestatedAnnual report

    「28 June 2017 Annual General Meeting of Shareholders Common stock 27,799 5.00」

    The payment of a ¥5 per-share dividend on common stock, with 31 March 2017 as the record date, is disclosed.
  30. FY2017SoftenedAnnual report

    「The Company decided to pay a year-end dividend of ¥5 per share for the current fiscal year, funded from retained earnings.」

    The year-end dividend on common stock was ¥5 per share, a nominal decrease from ¥10 per share in the previous fiscal year.
  31. FY2017-Q3RestatedAnnual report

    「28 June 2016 Annual General Meeting of Shareholders Common stock 27,799 10.00」

    A dividend of ¥27,799 thousand, or ¥10.00 per share, was paid on common stock; this is a repeat disclosure.
  32. FY2017-Q2RestatedAnnual report

    「28 June 2016 Annual General Meeting of Shareholders Common stock 27,799 10.00」

    A dividend of ¥27,799 thousand, or ¥10.00 per share, was paid on common stock; this is a repeat disclosure.
  33. FY2017-Q1First statedAnnual report

    「28 June 2016 Annual General Meeting of Shareholders Common stock 27,799 10.00」

    Based on a resolution of the Annual General Meeting of Shareholders, dividends of ¥27,799 thousand, or ¥10.00 per share, were paid on common stock.
Moved together

"Continued growth in net income attributable to owners of the parent and monitoring of real estate-related indicators" moved the same way as this thread, in the same document, in 4 of its 33 moves.

444444★123456
  1. ★This thread
  2. 1Continued growth in net income attributable to owners of the parent and monitoring of real estate-related indicators4×
  3. 2Risk of joint and several guarantee obligations for SPC borrowings4×
  4. 3Developing the hospital-related business into a growth area and core business4×
  5. 4Bad-debt risk from deterioration in the financial condition of partner medical institutions4×
  6. 5Determination and execution of property exit strategies4×
  7. 6Risk of losses on investments in and loans to 株式会社DAホールディングス and its subsidiaries4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for GLOME Holdings yet. It last moved in the Results of 2026-08-14: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.